IOVA - Company ID 0001425205
The table below shows IOVANCE BIOTHERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $196.51M | $158.13M | $132.47M | $171.67M | $164.19M | $228.68M |
| Short-term investments | $116.94M | $142.67M | $168.71M | $188.04M | $233.30M | $183.86M |
| Receivables | $81.76M | $66.76M | $59.94M | $70.94M | $55.77M | $31.60M |
| Inventory | $58.38M | $51.71M | $49.83M | $65.55M | $38.58M | $27.85M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $466.50M |
| $429.09M |
| $422.50M |
| $512.65M |
| $498.58M |
| $482.26M |
| Property, plant & equipment | $131.39M | $126.65M | $122.47M | $111.58M | $112.52M | $110.96M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $925.66M | $904.95M | $907.44M | $966.74M | $991.12M | $964.32M |
| Accounts payable | $37.45M | $31.24M | $32.00M | $28.49M | $31.69M | $20.42M |
| Total current liabilities | $129.42M | $125.78M | $129.16M | $122.69M | $118.06M | $93.64M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $203.91M | $202.66M | $208.95M | $198.88M | $217.66M | $195.78M |
| Retained earnings | -$2.85B | -$2.70B | -$2.61B | -$2.50B | -$2.31B | -$2.22B |
| Total equity | $721.75M | $702.29M | $698.49M | $767.87M | $773.46M | $768.54M |